TCMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
TACTILE SYSTEMS TECHNOLOGY INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$22.73+0.21 (+0.93%)
Close on Oct 19, 2026
- Market cap
- $524.13M
- P/E (TTM)
- 21.0
- Dividend yield
- –
TACTILE SYSTEMS TECHNOLOGY INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales revenue | $76.49M | $66.97M | $92.70M | $76.89M | $70.53M | $52.47M | $75.27M | $63.17M | $64.27M | $53.31M | $68.03M | $58.87M | 89.3% | +8.4% |
| Lymphedema products | $73.63M | $62.22M | $89.48M | $72.38M | $65.97M | $50.55M | $77.08M | $65.28M | $64.68M | $52.31M | $69.46M | $62.51M | 85.9% | +11.6% |
| Airway clearance products | $12.07M | $13.05M | $14.12M | $13.37M | $12.94M | $10.71M | $8.50M | $7.81M | $8.54M | $8.78M | $8.19M | $7.08M | 14.1% | -6.7% |
| Rental revenue | $9.21M | $8.30M | $10.89M | $8.87M | $8.37M | $8.80M | $10.32M | $9.93M | $8.95M | $7.78M | $9.62M | $10.72M | 10.7% | +10.0% |
By region
From the segment and revenue-disaggregation notes of Tactile Systems Technology's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.